Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma

Author： Pink Joshua  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.5, 2012-05, pp. : 413-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation

By Deconinck Eric  

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

Mechanism-Based Pharmacokinetic-Pharmacodynamic Modelling of the Reversal of Buprenorphine-Induced Respiratory Depression by Naloxone: A Study in Healthy Volunteers

By Yassen Ashraf  

Clinical Pharmacokinetics, Vol. 46, Iss. 11, 2007-01 ,pp. : 965-980

Adis International

Access to resources Recommend Favorite

Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis

By Prica Anca   Chan Kelvin   Cheung Matthew  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2637-2645

Blackwell Publishing

Access to resources Recommend Favorite

NICE recommends rituximab for follicular lymphoma . . .

By  

Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic evaluation of tigecycline

By Giamarellou Helen   Poulakou Garyphallia  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1459-1470

Informa Healthcare

Access to resources Recommend Favorite